Icosavax, Inc.
ICVX · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $388 | $445 | $239 | $316 |
| - Cash | $63 | $155 | $49 | $59 |
| + Debt | $8 | $8 | $9 | $9 |
| Enterprise Value | $333 | $298 | $199 | $266 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | -$1 | -$1 | -$2 |
| % Margin | – | – | – | – |
| EBITDA | -$25 | -$29 | -$25 | -$25 |
| % Margin | – | – | – | – |
| Net Income | -$22 | -$26 | -$23 | -$21 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.44 | -0.59 | -0.55 | -0.54 |
| % Growth | 25.4% | -7.3% | -1.9% | – |
| Operating Cash Flow | -$19 | -$19 | -$22 | -$9 |
| Capital Expenditures | -$0 | -$1 | -$2 | -$3 |
| Free Cash Flow | -$19 | -$20 | -$23 | -$12 |